1. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med 2010;38(4 suppl):S512-S521.
2. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease-life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-1644.
3. Ashley-Koch A, Yang Q, Olney RS. Sickle hemoglobin (Hb S) allele and sickle cell disease: a HuGE review. Am J Epidemiol 2000;151:839-845.
4. Pauling L, Itano HA, Singer SJ, et al. Sickle cell anemia: a molecular disease. Science 1949;110:543-548.
5. Bediako SM. Psychosocial aspects of sickle cell disease: a primer for African American psychologists. In: Neville HA, Tynes BM, Utsey SO, , eds. Handbook of African American Psychology. Thousand Oaks, CA:Sage Publications;2009;:417-427.
6. McGann PT, Nero AC, Ware RE. Clinical features of β-thalassemia and sickle cell disease. Adv Exp Med Biol 2017;1013:1-26.
7. Ballas SK. Defining the phenotypes of sickle cell disease. Hemoglobin 2011;35:511-519.
. Dampier C, LeBeau P, Rhee S, et al. Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium. Am J Hematol 2011;86:203-205.
9. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004;364:1343-1360.
10. Gil KM, Carson JW, Porter LS, et al. Daily mood and stress predict pain, health care use, and work activity in African American adults with sickle-cell disease. Health Psychol 2004;23:267-274.
11. Levenson JL, McClish DK, Dahman BA, et al. Depression and anxiety in adults with sickle cell disease: the PiSCES project. Psychosom Med 2008;70:192-196.
12. Porter LS, Gil KM, Carson JW, et al. The role of stress and mood in sickle cell disease pain: an analysis of daily diary data. J Health Psychol 2000;5:53-63.
13. Wallen GR, Minniti CP, Krumlauf M, et al. Sleep disturbance, depression and pain in adults with sickle cell disease. BMC Psychiatry 2014;14:207.
14. Gibson RC, Morgan KAD, Abel WD, et al. Locus of control, depression and quality of life among persons with sickle cell disease in Jamaica. Psychol Health Med 2013;18:451-460.
15. Imhonde HO, Ndom RJ, Ehon A. Social-support, self-esteem and depression as determinants of quality of life among sickle cell patients. IFE Psychologia 2013;21:101-113.
16. Grant MM, Gil KM, Floyd MY, et al. Depression and functioning in relation to health care use in sickle cell disease. Ann Behav Med 2000;22:149-157.
17. Thomas VJ, Gruen R, Shu S. Cognitive-behavioural therapy for the management of sickle cell disease pain: identification and assessment of costs. Ethnic Health 2001;6:59-67.
18. Alao AO, Cooley E. Depression and sickle cell disease. Harvard Rev Psychiat 2001;9:169-177.
19. Alao AO, Dewan MJ, Jindal S, et al. Psychopathology in sickle cell disease. W Afr J Med 2004;22:334-337.
20. Hasan SP, Hashmi S, Alhassen M, et al. Depression in sickle cell disease. J Natl Med Assoc 2003;95:533-537.
21. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-396.
22. Porter LS, Gil KM, Sedway JA, et al. Pain and stress in sickle cell disease: an analysis of daily pain records. Int J Behav Med 1998;5:185-203.
23. An K, Salyer J, Brown RE, et al. Salivary biomarkers of chronic psychosocial stress and CVD risks: a systematic review. Biol Res Nurs 2016;18:241-263.
24. Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 2004;130:601-630.
25. Edwards CL, Killough A, Wood M, et al. Emotional reactions to pain predict psychological distress in adult patients with sickle cell disease (SCD). Int J Psychiatry Med 2014;47:1-16.
26. Edwards CL, Green M, Wellington CC, et al. Depression, suicidal ideation, and attempts in black patients with sickle cell disease. J Nat Med Assoc 2009;101:1090-1095.
27. Molock SD, Belgrave FZ. Depression and anxiety in patients with sickle cell disease: conceptual and methodological considerations. J Health Soc Policy 1994;5:39-53.
28. Cohen S, Kessler RC, Gordon LU. Strategies for measuring stress in studies of psychiatric and physical disorders. In: Cohen S, Kessler RC, Gordon LU, , eds. Measuring Stress: A Guide for Health and Social Scientists. New York:Oxford University Press;1995;:3-26.
29. Engel GL. The need for a new medical model: a challenge for biomedicine. Science 1977;196:129-136.
30. Lazarus RS, Folkman S. Stress, Appraisal, and Coping. New York:Springer;1984.
31. Laurence B, George D, Woods D. Association between elevated depressive symptoms and clinical disease severity in African-American adults with sickle cell disease. J Natl Med Assoc 2006;98:365-369.
32. Mahdi N, Al-Ola K, Khalek NA, et al. Depression, anxiety, and stress comorbidities in sickle cell anemia patients with vaso-occlusive crisis. J Pediatr Hematol Oncol 2010;32:345-349.
33. Barakat LP, Patterson CA, Daniel LC, et al. Quality of life among adolescents with sickle cell disease: mediation of pain by internalizing symptoms and parenting stress. Health Qual Life Outcomes 2008;6:60.
34. Valrie CR, Gil KM, Redding-Lallinger R, et al. Daily mood as a mediator or moderator of the pain-sleep relationship in children with sickle cell disease. J Pediatr Psychol 2008;33:317-322.
35. Cohen S, Janicki-Deverts D, Miller GE. Psychological stress and disease. JAMA 2007;298:1685-1687.
36. Ganzel BL, Morris PA, Wethington E. Allostasis and the human brain: integrating models of stress from the social and life sciences. Psychol Rev 2010;117:134-174.
37. Miller GE, Chen E, Zhou ES. If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary adrenocortical axis in humans. Psychol Bull 2007;133:25-45.
38. Mathews A, MacLeod C. Cognitive vulnerability to emotional disorders. Ann Rev Clin Psychol 2005;1:167-195.
39. Beck AT, Clark DA. Anxiety and depression: an information processing perspective. Anx Res 1988;1:23-36.
40. Bediako SM, Lattimer L, Haywood C, Jr et al. Religious coping and hospital admissions among adults with sickle cell disease. J Behav Med 2011;34:120-127.
41. Edwards R, Telfair J, Cecil H, et al. Self-efficacy as a predictor of adult adjustment to sickle cell disease:one-year outcomes. Psychosom Med 2001;63:850-858.
42. Derogatis LR. BSI Brief Symptom Inventory: Administration, Scoring, and Procedure Manual. Minneapolis, MN: National Computer Systems; 1993.
43. Hayes AF. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. New York: Guilford Press; 2013.
44. Wellington C, Edwards CL, McNeil J, et al. Somatization in the conceptualization of sickle cell disease. J Natl Med Assoc 2010;102:1079-1083.
45. Anie KA, Green J. Psychological therapies for sickle cell disease and pain. Cochrane Database Syst Rev 2015;5:CD001916.
46. Edwards LY, Edwards CL. Psychosocial treatments in pain management of sickle cell disease. J Natl Med Assoc 2010;102:1084-1094.
47. Abdullah T, Brown TL. Mental illness stigma and ethnocultural beliefs, values, and norms: an integrative review. Clin Psychol Rev 2011;31:934-948.
48. Jenerette C, Funk M, Murdaugh C. Sickle cell disease: a stigmatizing condition that may lead to depression. Issues Ment Health Nurs 2005;26:1081-1101.
49. Jonassaint CR, Jones VL, Leong S, et al. A systematic review of the association between depression and health care utilization in children and adults with sickle cell disease. Br J Haemotol 2016;174:136-147.